MiNK Therapeutics, Inc.
INKT
$10.72
$0.212.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 9.89% | 31.86% | -53.17% | -12.33% | -36.34% |
| Total Depreciation and Amortization | -11.67% | -10.45% | -3.94% | -5.75% | -13.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -97.56% | -42.05% | 85.27% | 11.52% | 159.03% |
| Change in Net Operating Assets | -55.76% | -9.11% | 97.51% | 2,861.68% | 64.33% |
| Cash from Operations | -120.30% | 40.01% | -17.03% | 22.39% | 42.31% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -90.04% | 2,709,040.00% | -16.67% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -91.32% | 2,709,040.00% | -16.67% | -- | -100.00% |
| Foreign Exchange rate Adjustments | -344.00% | -131.85% | 972.22% | 92.34% | -970.37% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -107.31% | 911.29% | -15.71% | 23.36% | 41.34% |